Evidence map›Paper›PMID 35388735›Full record

ArticleGut microbes

Matthew Davies, Gianluca Galazzo, Jarne M van Hattem, Maris S Arcilla, Damian C Melles, Menno D de Jong, Constance Schultsz, Petra Wolffs, Alan McNally, Willem van Schaik and 1 more

Open access · goldAbstract read
In one paragraph

Article in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 35 citations in OpenAlex.

  1. Domestic travel as a driver for the dissemination ofAntimicrobial agents and chemotherapy · 2026
    Article
  2. Article
  3. Article
  4. Metagenomics reveals an increased proportion of anJournal of Zhejiang University. Science. B · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. The Roles of a Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Matthew DaviesInstitute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
Gianluca GalazzoDepartment of Medical Microbiology, School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.ORCID 0000-0001-9252-3447
Jarne M van HattemDepartment of Medical Microbiology, Amsterdam University Medical Center, AMC, Amsterdam, The Netherlands.
Maris S ArcillaDepartment of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Damian C MellesDepartment of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Menno D de JongDepartment of Medical Microbiology, Amsterdam University Medical Center, AMC, Amsterdam, The Netherlands.ORCID 0000-0002-8380-4738
Constance SchultszDepartment of Medical Microbiology, Amsterdam University Medical Center, AMC, Amsterdam, The Netherlands.ORCID 0000-0003-2280-7844
Petra WolffsDepartment of Medical Microbiology, School of Public Health and Primary Care (CAPHRI), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.ORCID 0000-0002-5326-3985
Alan McNallyInstitute of Microbiology and Infection, University of Birmingham, Birmingham, UK.ORCID 0000-0002-3099-630X
Willem van SchaikInstitute of Microbiology and Infection, University of Birmingham, Birmingham, UK.ORCID 0000-0001-5832-0988
John PendersDepartment of Medical Microbiology, School of Public Health and Primary Care (CAPHRI), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.ORCID 0000-0001-9146-5919
Maastricht University Medical Centre · NLAmsterdam University Medical Centers · NLErasmus MC · NLUniversity of Birmingham · GBAmsterdam Institute for Global Health and Development · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies have shown high acquisition risks of extended-spectrum beta-lactamase-producing

Indexed as

Enterobacteriaceae InfectionsGastrointestinal MicrobiomeAnti-Bacterial AgentsBacteriaBacteroidaceaebeta-LactamasesDiarrheaEnterobacteriaceaeEscherichia coliHumansTravelAnti-Bacterial Agentsbeta-Lactamasesantimicrobial resistanceExtended-spectrum beta-lactamasemetagenomemicrobiometravel

Identifiers

PMID35388735
PMCPMC8993065
OpenAlexW4223578137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.